Investigators from Shanghai, China, report responses above 90% by using levantinib and tislelizumab to treat patients with a ...
The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback